Table 2.
The changes in the clinical data
| Normal range | Day 1 | Day 9 | Day 51 | Day 71 | Day 99 | Day 135 | Day 176 | Day 197 | |
|---|---|---|---|---|---|---|---|---|---|
| Proteinuria (g/gCre) | <0.15 | 0.52 | 0.14 | 0.1 | 0.07 | 0.06 | 0.05 | 0.07 | 0.06 |
| NAG (U/l) | <7 | 13.1 | 3.3 | nd | nd | nd | nd | nd | 1.8 |
| β2-MG (μg/l) | <230 | 1172 | 2215 | nd | nd | nd | nd | nd | 640 |
| WBC (/μl) | 3500–9200 | 3300 | 9000 | 10800 | 11300 | 7800 | 10100 | 8200 | 8900 |
| Lymphocytes (%) | 30–45 | 7.0 | 8.7 | 9.8 | 21.0 | 23.0 | 13.0 | 16.0 | 13.5 |
| eGFR (ml/min) | 67.3 | 85.9 | 102.6 | 101.0 | 94.3 | 92.9 | 91.5 | 90.2 | |
| Albumin (serum) (g/dl) | 3.8–5.3 | 2.5 | 2.8 | 3.8 | 3.5 | 3.6 | 3.6 | 3.7 | 3.5 |
| AST (IU/l) | 13–33 | 186 | 19 | 20 | 35 | 40 | 38 | 28 | 22 |
| CH50 (U/ml) | 30–50 | 19 | nd | 41.1 | 37.4 | 38.8 | 39.7 | 38.3 | 38.3 |
| Anti-dsDNA Ab (IU/ml) | <20 | 53 | nd | 192 | nd | 123 | nd | 122 | 104 |
| Anti-nuclear Ab (titer) | <1:40 | 1:80 | nd | 1:80 | nd | 1:80 | nd | 1:80 | 1:160 |
| sIL-2R (U/ml) | 145–519 | 2770 | nd | 746 | nd | 817 | nd | 623 | 657 |
| Major axis of the left kidney (mm) | 137.3 | nd | nd | nd | nd | nd | nd | 121.6 | |
| Major axis of the right kidney (mm) | 134.8 | nd | nd | nd | nd | nd | nd | 127.6 |
Kidney sizes were measured by ultrasonography